Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Rocket Lab Tweets ‘Here’s to 2022. We’re coming for you, Moon’

https://twitter.com/RocketLab/status/1479523721400307713

byBenzinga Newsdesk

January 7, 2022

1 minute read

Here's to 2022. We're coming for you, Moon. pic.twitter.com/PJ3kCpJwLE

— Rocket Lab (@RocketLab) January 7, 2022

Barclays Shares Down 10% Monday; Earlier FT Article Highlights ‘The VXX plot thickens with Barclays’ £450m structured notes loss’

By Benzinga Newsdesk

Today, 5:05 AM

https://www.ft.com/content/386df3ee-4b9d-45c5-9ae1-d5dffb2a822e $

BCS

Tencent Fails To Win Gaming License Since China Lifted Suspension; Although NetEase Makes A Breakthrough

By Anusuya Lahiri

Today, 5:05 AM

China’s gaming regulator granted publishing licenses for 73 online games, including titles belonging to NetEase Inc (NASDAQ:NTES) and other developers, Reuters…

NAPRF

Cryptocurrency Ethereum Classic Decreases More Than 4% Within 24 hours

By Benzinga Insights

Today, 5:05 AM

Over the past 24 hours, Ethereum Classic's (CRYPTO: ETC) price has fallen 4.04% to $20.01. This continues its negative trend over the past week where it has experienced a 5.0% loss, moving from $20.97 to its current price.

$ETC

Technical Levels To Watch In Aytu BioPharma Stock

By Tyler Bundy

Today, 5:05 AM

Aytu BioPharma Inc. (NASDAQ: AYTU) shares were rallying Monday after retail traders were able to push the stock higher.

AYTU

Rocket Lab Tweets ‘Here’s to 2022. We’re coming for you, Moon’

Related Posts

Barclays Shares Down 10% Monday; Earlier FT Article Highlights ‘The VXX plot thickens with Barclays’ £450m structured notes loss’

Tencent Fails To Win Gaming License Since China Lifted Suspension; Although NetEase Makes A Breakthrough

Cryptocurrency Ethereum Classic Decreases More Than 4% Within 24 hours

Technical Levels To Watch In Aytu BioPharma Stock